<DOC>
	<DOCNO>NCT00758667</DOCNO>
	<brief_summary>The purpose study make available agent , Mesna , assist surgeon procedure capsulectomy .</brief_summary>
	<brief_title>Chemically Assisted Capsulectomy-A New Clinical Approach</brief_title>
	<detailed_description>Mesna FDA approve drug treatment respiratory disease use protective agent drug oncology patient . It also use Gynecologic surgery ENT . Mesna drug break adhesion tissue layer .</detailed_description>
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Implant Capsular Contracture</mesh_term>
	<mesh_term>Mesna</mesh_term>
	<criteria>All female undergo capsulectomy All pregnant woman nurse mother exclued</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>capsular contracture</keyword>
	<keyword>capsulectomy</keyword>
	<keyword>mesna</keyword>
	<keyword>Capsular contracture breast implant placement</keyword>
</DOC>